News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Japan will release 20 additional days of oil reserves in early May, extending supply measures after March's drawdown.
  • EU and U.S. near agreement to align critical-minerals policies to diversify suppliers and reduce Chinese market dominance.
  • U.S. futures were subdued as traders awaited March CPI and monitored a fragile U.S.-Iran two-week truce.
  • Atrium Ljungberg's Q1 net profit halved on unrealised property valuation losses and office vacancies, pushing loan-to-value higher.
  • Citi finds Brent crude above $80 and its 200-day average correlates with USD/JPY remaining above its 200-day average.
  • WFP warns Lebanon's food access has plummeted as regional conflict disrupts supply lines and pushes prices up.
  • Organon shares jumped after reports Sun Pharma prepared a binding $12 billion bid following months of due diligence.

Latest Articles

Lebanon braces for prolonged displacement as funding and shelter shortfalls deepen

Lebanon braces for prolonged displacement as funding and shelter shortfalls deepen

Lebanon’s social affairs ministry is preparing for the real possibility that large numbers of people who fled southern areas after Israeli strikes and evacuation orders will not return home in the near future, the minister said. With pledges and deliveries of international aid far below levels seen during last year’s conflict, officials are conside…

Klarna: A Contrarian Dip-Buy Where Value Meets Value Trap Risk

Klarna: A Contrarian Dip-Buy Where Value Meets Value Trap Risk

Klarna's pullback has turned it into a high-risk, high-reward dip-buy. The payments-to-lending hybrid trades at a price that suggests muted growth and continued loss absorption. If you believe management can stabilize credit losses and refocus the business on higher-margin product flows, the trade offers asymmetric upside. If not, the stock can sta…

When Attacks on Civilian Infrastructure Cross into War Crimes

When Attacks on Civilian Infrastructure Cross into War Crimes

As hostilities linked to the widening Iran conflict have included strikes and threats against oil, electricity and desalination installations that serve civilians, legal experts say such actions can amount to war crimes if they meet specific international-law criteria. The Geneva Conventions, the Rome Statute and recent ICC casework provide the leg…

Supreme Court Allows Challenge to Colorado Ban on Conversion Therapy for Minors

Supreme Court Allows Challenge to Colorado Ban on Conversion Therapy for Minors

The U.S. Supreme Court on Tuesday sided with a licensed Christian counselor challenging Colorado’s 2019 statute that bars licensed mental health professionals from providing so-called conversion therapy to minors aimed at changing sexual orientation or gender identity. In an 8-1 decision, the justices overturned a lower court ruling that had upheld…

PBF Energy: Ride the Refining Windfall While It Lasts (Buy)

PBF Energy: Ride the Refining Windfall While It Lasts (Buy)

PBF Energy (PBF) is a buy for a mid-term trade. Geopolitical disruptions at the Strait of Hormuz and record diesel/gasoline prices have pushed U.S. crack spreads to multi-year highs, and PBF's refining footprint, low valuation versus potential earnings, and recent technical momentum argue for a tactical long. Entry at current levels, tight stop, an…

AI-Flagged US Stocks Deliver Double-Digit March Gains as Market Wobbles

AI-Flagged US Stocks Deliver Double-Digit March Gains as Market Wobbles

US equities have been volatile in March, but a set of stock selections generated by an AI stock-picking system produced substantial, sometimes double-digit, returns for subscribers. Notable winners since selection include Occidental Petroleum (OXY) up 61.09%, Chevron (CVX) up 39.60% and Onto Innovation (ONTO) up 19.90%. The platform also highlights…

Westlake Executive Sells $461,000 in Stock as Analysts Raise Targets

Westlake Executive Sells $461,000 in Stock as Analysts Raise Targets

Robert F. Buesinger, Executive Vice President and PEM Segment Head at Westlake Corp (WLK), sold 4,000 shares on March 27, 2026, generating proceeds of $461,000. The transaction comes as the shares trade close to their 52-week high and after the company reported a material fourth-quarter 2025 earnings miss. Several brokerages have, however, increase…

Appeals Court Upholds Dismissal of Criminal Case Against Boeing

Appeals Court Upholds Dismissal of Criminal Case Against Boeing

A three-judge panel of the U.S. Court of Appeals for the 5th Circuit on Tuesday affirmed a lower court ruling that approved the Justice Department's decision to dismiss a criminal charge against Boeing tied to two fatal 737 MAX crashes that together killed 346 people. The district judge had said he lacked authority to overturn the government's choi…

BofA: Thai Growth Lost Steam in February as External Pressures Rose

BofA: Thai Growth Lost Steam in February as External Pressures Rose

A Bank of America (BofA) report finds Thailand’s economic momentum eased in February, with slower export growth, softer industrial output and a pullback in household spending. Tourism and services also weakened month-on-month, even as the current account surplus strengthened on a swing to a trade surplus and an improved services balance.

Snowflake shares slip after CRO succession announced

Snowflake shares slip after CRO succession announced

Snowflake shares fell about 4% following the company’s announcement that Jonathan Beaulier will assume the role of Chief Revenue Officer on March 31, 2026, replacing Mike Gannon, who is leaving for personal reasons. Beaulier, a Snowflake employee since 2016, most recently served as GVP, U.S. Majors Sales and previously led sales for Financial Servi…

MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

MAIA Biotechnology announced promising results from its Phase 2 THIO-101 clinical trial in non-small cell lung cancer (NSCLC), where eight patients treated with ateganosine followed by cemiplimab showed overall survival exceeding two years without subsequent therapy. This suggests ateganosine may be an effective telomere-targeting immunotherapy for…